Terms ending in 2031
Every in-force patent on kaleo, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,192,464 | Medicament Delivery Device Configured to Produce Wireless and Audible Outputs In force · High confidence | Intelliject, Inc. | In force | High confidence | |
| US 8,939,943 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · High confidence | Kaleo, Inc. | In force | High confidence | |
| US 9,022,022 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · Low confidence | Kaleo, Inc. | In force | Low confidence | |
| US 9,474,869 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · High confidence | Kaleo, Inc. | In force | High confidence | |
| US 9,814,838 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · High confidence | Kaleo, Inc. | In force | High confidence | |
| US 10,322,239 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · High confidence | Kaleo, Inc. | In force | High confidence | |
| US 10,143,792 | Medicament Delivery Device for Administration of Opioid Antagonists Including Formulations for Naloxone In force · High confidence | Kaleo, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.